Clinical Trials Directory

Trials / Completed

CompletedNCT05982197

Curcumin Gel On Radiation Induced Oral Mucositis

The Effect of Curcuma Long Oral Gel in Relation to Salivary Epidermal Growth Factor & Interleukin-8 on Radiation Induced Oral Mucositis in Iraqi Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Baghdad · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical study is to investigate the effect of a curcuma longa oral gel (curenext) on reducing radiation-induced oral mucositis severity in cancer patients and provide a context for understanding if there is a relationship between the curcumin clinical effect and production of EGFs and IL8. Researchers will compare between curcumin group and standard treatment group.

Conditions

Interventions

TypeNameDescription
DRUGCurcumin GelCurcuma longa oral gel for prevention radiation induced oral mucositis
DRUGStandard PreparationStandard preparation for prevention radiation induced oral mucositis

Timeline

Start date
2023-01-03
Primary completion
2023-03-01
Completion
2023-07-02
First posted
2023-08-08
Last updated
2023-08-08

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT05982197. Inclusion in this directory is not an endorsement.